NEW YORK, July 15 (Reuters) - Shares in AVI BioPharma Inc rose 22.1 percent to $1.99 in after hours trading on Thursday after the company said it was awarded a new contract with the U.S. Department of Defense chemical and biological defense program.
(Reporting by Edward Krudy; Editing by Philip Barbara) Keywords: MARKETS STOCKS AFTERTHEBELL (edward.krudy@thomsonreuters.com; Tel: +1 646-223-6314; Reuters Messaging: edward.krudy@reuters.com@reuters.net) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
(Reporting by Edward Krudy; Editing by Philip Barbara) Keywords: MARKETS STOCKS AFTERTHEBELL (edward.krudy@thomsonreuters.com; Tel: +1 646-223-6314; Reuters Messaging: edward.krudy@reuters.com@reuters.net) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.